Baxter recently stopped selling IV products in China as it continues its efforts to address hurricane-related supply shortages in the U.S. In a statement shared with Pharmaceutical Processing World, the Deerfield, Illinois–based company said: “After careful consideration, and given the numerous alternative IV solution suppliers that exist in the Chinese market, Baxter has suspended commercial…
Baxter bolsters fill-finish capabilities with $100M investment in Germany
Baxter International (NYSE:BAX) plans to invest roughly $100 million to expand a sterile fill-finish manufacturing plant in Halle/Westfalen, Germany. BioPharma Solutions (BPS), a subsidiary of Deerfield, Illinois–based Baxter, will manage the new facility. BPS supports pharmaceutical companies through a range of offerings, including scientific support, sterile contract manufacturing and parenteral delivery systems. Baxter anticipates that…
Baxter BioPharma invests $50M in fill/finish manufacturing plant
Baxter (NYSE:BAX) is planning on spending $50 million to expand a sterile fill/finish manufacturing facility in Bloomington, Ind. Baxter’s BioPharma Solutions business will manage the site, including a new 25,000-ft2 warehouse, a new filling line for flexible plastic containers and a high-speed automated syringe fill line. Baxter hopes to wrap up manufacturing at the site in…